awmsg logo



lidocaine/prilocaine (Fortacin®)


Reference No. 1846

Publication date:
08/05/2014


Appraisal information

lidocaine/prilocaine (Fortacin®) 150 mg/50 mg/ml cutaneous spray solution


Company: Plethora Solutions Holdings PLC
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 07/05/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, lidocaine/prilocaine (Tempe®) cannot be endorsed for use within NHS Wales for the treatment of primary premature ejaculation in adult men.
Statement of Advice (SOA)
Download